463 related articles for article (PubMed ID: 10067266)
1. LYS-plasminogen shortens the duration of local thrombolytic treatment of peripheral arterial occlusions--a randomized controlled trial.
Poredos P; Videcnik V
Wien Klin Wochenschr; 1999 Jan; 111(1):21-5. PubMed ID: 10067266
[TBL] [Abstract][Full Text] [Related]
2. Intra-coronary thrombolysis with streptokinase or lys-plasminogen/urokinase in acute myocardial infarction: effects on recanalization and blood fibrinolysis.
de Prost D; Guerot C; Laffay N; Horellou MH; Samama M
Thromb Haemost; 1983 Dec; 50(4):792-6. PubMed ID: 6665760
[TBL] [Abstract][Full Text] [Related]
3. [Local thrombolysis in peripheral arterial occlusion].
Hess H
Herz; 1989 Feb; 14(1):12-21. PubMed ID: 2522076
[TBL] [Abstract][Full Text] [Related]
4. The systemic fibrinolytic effect of BRL 26921 during the treatment of acute peripheral arterial occlusions.
Earnshaw JJ; Westby JC; Makin GS; Hopkinson BR
Thromb Haemost; 1986 Apr; 55(2):259-62. PubMed ID: 3520938
[TBL] [Abstract][Full Text] [Related]
5. [Results of in situ arterial thrombolysis by the combination of urokinase and lysyl plasminogen in acute arterial occlusive diseases of the lower limbs].
Pernes JM; Brenot P; Raynaud A; Parola JL; Roth JP; Angel CY; Vitoux JF; Fiessinger JN; Roncato M; Gaux JC
J Radiol; 1985 May; 66(5):385-91. PubMed ID: 4032349
[TBL] [Abstract][Full Text] [Related]
6. [Systemic thrombolysis of arterial occlusions of the lower extremities. Comparison of various treatment schedules].
Lämmle B; Noll G; Christe M; Fritschi J; Czendlik C; Marbet GA; Biland L; Da Silva A; Huber P; Widmer LK
Schweiz Med Wochenschr; 1983 Oct; 113(43):1570-6. PubMed ID: 6227992
[TBL] [Abstract][Full Text] [Related]
7. Prospective randomized trial of high-dose bolus versus low-dose tissue plasminogen activator infusion in the management of acute limb ischaemia. Thrombolysis Study Group.
Braithwaite BD; Buckenham TM; Galland RB; Heather BP; Earnshaw JJ
Br J Surg; 1997 May; 84(5):646-50. PubMed ID: 9171752
[TBL] [Abstract][Full Text] [Related]
8. A study of the use of the thromboxane A2 antagonist, sulotroban, in combination with streptokinase for local thrombolysis in patients with recent peripheral arterial occlusions: clinical effects, platelet function and fibrinolytic parameters.
Lonsdale RJ; Heptinstall S; Westby JC; Berridge DC; Wenham PW; Hopkinson BR; Makin GS
Thromb Haemost; 1993 Feb; 69(2):103-11, 123. PubMed ID: 8456421
[TBL] [Abstract][Full Text] [Related]
9. [Local intra-arterial thrombolysis in acute ischemia of an extremity].
Enevoldsen MT; Rørdam P; Schroeder TV
Ugeskr Laeger; 1996 Sep; 158(36):5011-4. PubMed ID: 8928238
[TBL] [Abstract][Full Text] [Related]
10. [Fibrinolytic therapy of acute arterial occlusions in the lower extremities].
Treska V; Valenta J; Emmerová M
Cas Lek Cesk; 1990 Apr; 129(14):429-31. PubMed ID: 2344599
[TBL] [Abstract][Full Text] [Related]
11. Studies on the medical treatment of deep vein thrombosis.
Schulman S
Acta Med Scand Suppl; 1985; 704():1-68. PubMed ID: 3913282
[TBL] [Abstract][Full Text] [Related]
12. Thrombolytic therapy for acute arterial occlusion.
Sicard GA; Schier JJ; Totty WG; Gilula LA; Walker WB; Etheredge EE; Anderson CB
J Vasc Surg; 1985 Jan; 2(1):65-78. PubMed ID: 3965760
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolytic profiles in local low-dose thrombolysis with streptokinase and recombinant tissue plasminogen activator.
Berridge DC; Earnshaw JJ; Westby JC; Makin GS; Hopkinson BR
Thromb Haemost; 1989 Apr; 61(2):275-8. PubMed ID: 2501898
[TBL] [Abstract][Full Text] [Related]
14. Review of studies with plasminogen concentrates and proposals for further therapeutic strategies with plasminogen concentrates.
Anderle K; Fröhlich A
Haemostasis; 1988; 18 Suppl 1():165-75. PubMed ID: 3280422
[TBL] [Abstract][Full Text] [Related]
15. Peripheral arterial occlusions: a 6-year experience with local low-dose thrombolytic therapy.
Hess H; Mietaschk A; Brückl R
Radiology; 1987 Jun; 163(3):753-8. PubMed ID: 3575727
[TBL] [Abstract][Full Text] [Related]
16. [Heparin and plasminogen increase the thrombolytic potential in recanalization of peripheral arterial occlusions by local streptokinase].
Poredos P; Videcnik V
Vasa Suppl; 1992; 37():62-3. PubMed ID: 1481104
[No Abstract] [Full Text] [Related]
17. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR
Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011
[TBL] [Abstract][Full Text] [Related]
18. [Treatment with the urokinase-lysyl plasminogen combination of developmental outbreaks of arteriopathies].
Vitoux JF; Roncato M; Pernes JM; Fiessinger JN; Aiach M; Gaux JC
Ann Med Interne (Paris); 1986; 137(2):105-7. PubMed ID: 3717814
[TBL] [Abstract][Full Text] [Related]
19. Sequential treatment of arterial occlusions with porcine plasmin and low dose streptokinase.
Marbet GA; Eichlisberger R; Duckert F; da Silva MA; Biland L; Widmer LK; Ritz R; Schmitt HE
Thromb Haemost; 1982 Oct; 48(2):187-9. PubMed ID: 6217580
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial of China-made recombinant streptokinase in acute myocardial infarction. Collaborative Study Group on Thrombolysis with China-made recombinant streptokinase.
Chin Med J (Engl); 1997 Jan; 110(1):50-2. PubMed ID: 9594322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
